Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.

PubWeight™: 1.71‹?› | Rank: Top 3%

🔗 View Article (PMID 18207312)

Published in Eur Urol on January 15, 2008

Authors

Satoru Kawakami1, Noboru Numao, Yuhei Okubo, Fumitaka Koga, Shinya Yamamoto, Kazutaka Saito, Yasuhisa Fujii, Junji Yonese, Hitoshi Masuda, Kazunori Kihara, Iwao Fukui

Author Affiliations

1: Department of Urology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan. s-kawakami@tmd.ac.jp

Articles citing this

An overview of prostate diseases and their characteristics specific to Asian men. Asian J Androl (2012) 0.96

Initial biopsy outcome prediction in Korean patients-comparison of a noble web-based Korean prostate cancer risk calculator versus prostate-specific antigen testing. J Korean Med Sci (2010) 0.94

A nomogram based on age, prostate-specific antigen level, prostate volume and digital rectal examination for predicting risk of prostate cancer. Asian J Androl (2012) 0.94

Nomogram using transrectal ultrasound-derived information predicting the detection of high grade prostate cancer on initial biopsy. Prostate Int (2013) 0.83

Artificial neural networks and prostate cancer--tools for diagnosis and management. Nat Rev Urol (2013) 0.83

Editorial comment on: development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy. Eur Urol (2008) 0.82

The optimal number of initial prostate biopsy cores in daily practice: a prospective study using the Nara Urological Research and Treatment Group nomogram. BMC Res Notes (2015) 0.79

Anatomic segmentation improves prostate cancer detection with artificial neural networks analysis of 1H magnetic resonance spectroscopic imaging. J Magn Reson Imaging (2013) 0.79

Systematic review of clinical features of suspected prostate cancer in primary care. Can Fam Physician (2015) 0.79

Random biopsy: when, how many and where to take the cores? World J Urol (2014) 0.78

Unmet needs in the prediction and detection of metastases in prostate cancer. Oncologist (2013) 0.78

A novel equation and nomogram including body weight for estimating prostate volumes in men with biopsy-proven benign prostatic hyperplasia. Asian J Androl (2012) 0.78

The value of an artificial neural network in the decision-making for prostate biopsies. World J Urol (2009) 0.77

External validation of an artificial neural network and two nomograms for prostate cancer detection. ISRN Urol (2012) 0.76

Articles by these authors

Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy. Eur Urol (2007) 2.15

Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy. Eur Urol (2007) 2.11

New three-dimensional head-mounted display system, TMDU-S-3D system, for minimally invasive surgery application: procedures for gasless single-port radical nephrectomy. Int J Urol (2012) 2.08

The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet (2004) 1.91

Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin Cancer Res (2003) 1.90

High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy. J Urol (2013) 1.76

Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study). Diabetes Care (2002) 1.70

Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma. Int J Urol (2011) 1.68

Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma. Eur Urol (2008) 1.67

Prognostic impact of C-reactive protein for determining overall survival of patients with castration-resistant prostate cancer treated with docetaxel. Urology (2011) 1.63

Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin Cancer Res (2009) 1.61

Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells. Int J Cancer (2011) 1.58

Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. Urology (2009) 1.53

Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate. BJU Int (2008) 1.52

Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL. Urology (2012) 1.48

Surgical practices for urological tumors: a nation-wide survey in Japan in 2005. Int J Urol (2009) 1.48

Muscle-invasive urothelial carcinoma of the bladder. Urology (2007) 1.46

Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy. BJU Int (2015) 1.46

Androgen receptors in gonadotrophs in pituitary cultures from adult male monkeys and rats. Endocrinology (2003) 1.46

Relationship between bone mineral density and androgen-deprivation therapy in Japanese prostate cancer patients. Urology (2010) 1.46

Do testosterone levels have prognostic significance in patients with metastatic prostate cancer treated with combined androgen blockade? Int J Urol (2014) 1.44

Tonotopic specialization of auditory coincidence detection in nucleus laminaris of the chick. J Neurosci (2005) 1.43

Young age as favorable prognostic factor for cancer-specific survival in localized renal cell carcinoma. Urology (2011) 1.43

Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer. BJU Int (2012) 1.42

Body mass index influences prostate cancer risk at biopsy in Japanese men. Int J Urol (2012) 1.42

Renal function after radical nephrectomy: development and validation of predictive models in Japanese patients. Int J Urol (2013) 1.42